Resources

Helpful downloadable resources
In this section, you will find useful resources that you can download to help you support your patients who are prescribed BOSULIF.
HCP resources
Dosing Guide
Dosing Guide
This helpful brochure contains detailed information on dosing, dose modifications, and help managing adverse reactions.
Expert Panel Review: Management of AEs for bosutinib
In 2018, an expert review panel of 7 hematologists discussing how they use BOSULIF as 1L or ≥2L in patients with CP-CML was published in the Journal of Hematology & Oncology. The full article, “Management of Adverse Events Associated With Bosutinib Treatment of Chronic-Phase Chronic Myeloid Leukemia: Expert Panel Review,” can be viewed on the journal site, linked below. A guide highlighting key takeaways is also available here for download. The FDA has not reviewed the recommendations contained in this reprint.
Patient resources
Patient Brochure
BOSULIF Patient Brochure
Help your patients start their journey with BOSULIF. Download this brochure, created specifically for patients with CML as a treatment resource, and learn more about what to expect throughout therapy.
AE=adverse event; Ph+=Philadelphia chromosome–positive.
Reference
1.
BOSULIF Prescribing Information. New York, NY: Pfizer Inc.